article thumbnail

Bayer to Present New Investigational Heart Failure Data, Continued Portfolio Research in Chronic Kidney Disease at ACC.25

DAIC

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25

article thumbnail

One Of The Biggest Impact Things You Can Do To Live Longer.

Dr. Paddy Barrett

Death from heart disease: 51% reduction in risk. Kidney Disease: 42% reduction in risk. The key point here is that not only do high levels of fitness make you likely to live longer, but it is also one of the best ways of improving your healthspan and quality of life as you age. Cancer deaths: 43% reduction in risk.

Exercise 119
article thumbnail

Is Anemia Common After Heart Bypass Surgery?

MIBHS

While cardiac surgery, including heart bypass surgery, can significantly improve quality of life and prevent further heart damage, patients may face various complications during or after the surgery, one of which is anemia. This can contribute to anemia, particularly in older patients or those with pre-existing kidney disease.

article thumbnail

Anemia Management in the Cardiorenal Patient: A Nephrological Perspective

Journal of the American Heart Association

Heart failure (HF) and chronic kidney disease (CKD) frequently coexist, sharing significant overlap in prevalence and pathophysiological mechanisms. Journal of the American Heart Association, Ahead of Print. There are no definitive guidelines for anemia management in CRS. Treatment should address HF, CKD, and anemia concurrently.

article thumbnail

National A-Fib Numbers Higher Than Previously Thought

DAIC

Fortunately, atrial fibrillation is preventable, and early detection and appropriate treatment can substantially reduce its adverse outcomes,” he said.

article thumbnail

Cardiology Team Performs Novel Heart Artery Repair with Newly Approved Device

DAIC

We are excited to offer our patients this novel treatment that offers meaningful improvement in quality of life without the high procedural risk often associated with tricuspid surgery,” said Gagan D. Left untreated, tricuspid regurgitation can lead to atrial fibrillation , heart failure , kidney disease and even death.

Tricuspid 111
article thumbnail

New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies

DAIC

PAD is a serious, progressive cardiovascular disease primarily caused by a buildup of fatty plaque in the blood vessels, or atherosclerosis. This plaque narrows the blood vessels and reduces blood flow to the legs and feet, which may significantly impair physical function, walking performance and quality of life.